These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 7291057)

  • 1. [The blood coagulation system in mitral valve defects].
    Kutarski A; Dmoszyńska-Giannopoulou A; Kowalewski J; Pluta A
    Pol Tyg Lek; 1980 Dec; 35(52):2047-50. PubMed ID: 7291057
    [No Abstract]   [Full Text] [Related]  

  • 2. [CO 2 gradient in mitral valve diseases].
    Sarno A; Caimi G; Amuso M; Adamo M
    Boll Soc Ital Cardiol; 1973; 18(11):1075-82. PubMed ID: 4807036
    [No Abstract]   [Full Text] [Related]  

  • 3. Relationship between control of ventricular rate in atrial fibrillation and systemic coagulation activation in patients with mitral stenosis.
    Atak R; Turhan H; Senen K; Yalta K; Ayaz S; Alyan O; Basar N; Demirkan D
    J Heart Valve Dis; 2004 Mar; 13(2):159-64. PubMed ID: 15086252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Blood rheology and central hemodynamics in rheumatic mitral valve diseases].
    Murashko VV; Dzhanashiia PKh; Shardanov NA; Kaĭdash AN; Khurtsilava SG
    Revmatologiia (Mosk); 1983; (2):26-9. PubMed ID: 6353510
    [No Abstract]   [Full Text] [Related]  

  • 5. [Evaluation of the hemodynamics in patients with mitral defects with the help of the dye dilution method with catheterisation of the right sections of the heart].
    Gorbachenkov AA; Vorob'ev GI; Solov'ev VV
    Klin Med (Mosk); 1966 May; 44(5):115-21. PubMed ID: 4865584
    [No Abstract]   [Full Text] [Related]  

  • 6. Mitral regurgitation reduces systemic coagulation activity in patients with rheumatic heart disease.
    Cevik C; Otahbachi M; Nugent K; Ozkan M
    J Heart Valve Dis; 2009 May; 18(3):278-83. PubMed ID: 19557983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prevention of thromboembolism in auricular fibrillation in mitral valve disease].
    Kałunzna J; Judkiewicz L; Pracka H; Moll J; Bolińska H; Zasłonka J
    Pol Tyg Lek; 1981 Aug; 36(34):1293-6. PubMed ID: 7335512
    [No Abstract]   [Full Text] [Related]  

  • 8. [Blood coagulation changes in heart valve stenoses].
    Cermák L
    Vnitr Lek; 1970 Oct; 16(10):972-7. PubMed ID: 5479242
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hemostasis and the rheologic properties of the blood in patients with rheumatic mitral stenosis].
    Dziak GV; Vulykh NV
    Vrach Delo; 1989 Jul; (7):82-4. PubMed ID: 2800514
    [No Abstract]   [Full Text] [Related]  

  • 10. A hypercoagulable state in the left atrium of patients with mitral stenosis.
    Yamamoto K; Ikeda U; Shimada K
    N Engl J Med; 1993 Apr; 328(14):1043-4. PubMed ID: 8450866
    [No Abstract]   [Full Text] [Related]  

  • 11. [Rheological and volemic properties of the blood in pregnant women with acquired heart defects].
    Serov VN; Nevrzorov OB
    Akush Ginekol (Mosk); 1981 Oct; (10):9-11. PubMed ID: 7316061
    [No Abstract]   [Full Text] [Related]  

  • 12. [Renin-angiotensin-aldosterone system and vasopressin in adult and aged patients with acquired mitral valve defects].
    Danilov AA; Grigor'iants RA; Masenko VP; Mukharliamov NM
    Kardiologiia; 1991 Aug; 31(8):67-9. PubMed ID: 1795480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Relationship of mitral valve area to hemostatic condition in rheumatic mitral stenosis].
    Kataoka H; Yano S; Mikuriya Y
    J Cardiol; 1994; 24(5):387-95. PubMed ID: 7932073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Echogram interpretation problems in rheumatic defects of the mitral valve].
    Gel'shteĭn GG; Zubkova GA
    Vopr Revm; 1980; (2):14-8. PubMed ID: 7405113
    [No Abstract]   [Full Text] [Related]  

  • 15. [The behavior of the heparin tolerance test in mitral patients].
    Romano V; Mininni N
    Rass Int Clin Ter; 1967 Jul; 47(13):743-5. PubMed ID: 5596881
    [No Abstract]   [Full Text] [Related]  

  • 16. [Incidence of valve calcifications in 200 patients with mitral valve disease].
    Mengozzi G; Balbarini A; Tartarini G; Giusti S; Nataloni M; Mariani M
    Minerva Cardioangiol; 1980; 28(1-2):21-4. PubMed ID: 7366851
    [No Abstract]   [Full Text] [Related]  

  • 17. [Mitral valve replacement with preservation of mitral valve device].
    Chen BT
    Zhonghua Wai Ke Za Zhi; 1993 Sep; 31(9):550-1. PubMed ID: 8033721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heart valve replacement; anticoagulation and pregnancy.
    Frimpong-Boateng K
    West Afr J Med; 2002; 21(2):163-5. PubMed ID: 12403045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case of valve thrombosis of CarboMedics prosthesis four years after mitral valve replacement: relationship of anticoagulant therapy to coagulation and fibrinolysis activating factors].
    Morishita A; Harada M; Hara M
    Kyobu Geka; 1996 Oct; 49(11):933-7. PubMed ID: 8913069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mitral valve replacement with a preserved subvalvular apparatus].
    Yang JF; Hu JG; Zhou XM
    Hunan Yi Ke Da Xue Xue Bao; 2002 Feb; 27(1):49-50. PubMed ID: 12575235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.